Dr. Robert A. Moyer, MD

Dr. Moyer practices at Infusion Solutions Of Delaware in Dover, Delaware.

Dr. Moyer's NPI, 1861477077, was assigned on December 9, 2005. Dr. Moyer graduated from Jefferson Medical College of Thomas Jefferson University in 1984. Dr. Moyer holds Delaware license C1-0003264.

Dr. Moyer's primary practice is Infusion Solutions of Delaware, at 1100 Forrest Ave, Dover, DE 19904-3309. The practice phone is (302) 674-4627.

Dr. Moyer's primary practice is Infusion Solutions Of Delaware in Dover, Delaware. Dr. Moyer is also affiliated with Bayhealth Hospital, Kent Campus. The medical group on file is Infusion Solutions of Delaware. Dmand AI also links Dr. Moyer to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moyer practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Moyer's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Moyer is licensed in Delaware.

CMS data shows 81,840 Medicare services from Dr. Moyer across 13 procedure codes in 2024, for 187 Medicare patients. Medicare paid $524,724 for them. Every service was in an office.

CMS counts 187 Medicare patients who saw Dr. Moyer in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moyer's median patient age at 72, with 73% women.

In 2024, Dr. Moyer wrote 389 Medicare Part D claims for 79 patients. 85% of them were for generic drugs. CMS names the drug for 234 of them, across 8 drugs with 11 or more claims each, at $7,362 in total drug cost. In 2023, CMS named 336 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Moyer for performance year 2024, reported as part of a group. Dr. Moyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moyer as offering telehealth.

Dmand AI links 15 papers to Dr. Moyer, published from 2010 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Cholinesterase Inhibitors, Chemical Warfare Agents and Acetylcholinesterase. Dr. Moyer has published most often in Toxicol Sci. Dr. Moyer's most frequent co-author is Manish R. Patel, MD.

CMS Open Payments shows 406 general payments to Dr. Moyer from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,043.

Dr. Moyer graduated from Jefferson Medical College of Thomas Jefferson University in 1984.